首页 > 市场调查报告书 > 製药

骨疾病

市场调查报告书

商品编码

1672944

银屑病干癣治疗市场按药物类别、产品类型、给药途径、分销管道和地区划分

Psoriatic Arthritis Treatment Market, By Drug Class, By Product Type, By Route of Administration, By Distribution Channel, By Geography

出版日期: 2025年02月19日 | 出版商:

Coherent Market Insights | 英文 260 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2025 年全球干癣性干癣治疗市场规模估计为 121.9 亿美元，预计到 2032 年将达到 234.7 亿美元，2025 年至 2032 年的复合年增长率为 9.8%。

报告范围		报告详细信息
基准年	2024	2025 年市场规模	121.9亿美元
效能资料	从 2020 年到 2024 年	预测期	2025 至 2032 年
预测期：2025-2032年复合年增长率：	9.80％	2032 年价值预测	234.7亿美元

数字。 2025 年干癣干癣治疗市场占有率（按地区划分）

干癣性关节炎是一种与干癣同时发生的慢性发炎性关节炎。据估计，大约 30% 的干癣患者会患上干癣性关节炎。这种疾病会导致关节内和关节周围疼痛、僵硬和肿胀。干癣性关节炎随着时间的推移会对关节造成永久性损伤。传统治疗方法包括使用胺基甲基叶酸和 TNF 抑制剂等缓解疾病的抗风湿药物 (DMARD) 来控制症状。全球银屑病干癣治疗市场的成长得益于安全性和有效性更好的新型生物目标的不断开发和核准。

市场动态：

全球银屑病干癣治疗市场的成长是由全球银屑病干癣盛行率的增加所推动的。据估计，该疾病的全球盛行率为 0.06% 至 1%。此外，人们对疾病的认识不断提高和先进治疗方法的普及也推动了市场的成长。然而，生物製药的高成本可能会阻碍市场成长，尤其是在价格敏感的新兴市场。市场开发商持续努力开发具有成本效益的学名药生物製药可以逐渐降低成本。此外，新兴经济体医疗保健支出的增加可能会在不久的将来为市场参与者提供新的机会。

本研究的主要特点

本报告对全球干癣性干癣治疗市场进行了详细分析，并以 2024 年为基准年，给出了预测期（2025-2032 年）的市场规模（十亿美元）和年复合成长率（CAGR%）。

它还强调了各个领域的潜在商机并说明了该市场的有吸引力的投资提案矩阵。

它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。

全球银屑病干癣治疗市场的主要企业是根据公司亮点、产品系列、关键亮点、财务表现和策略等参数进行的分析。

研究涉及的主要企业包括辉瑞、强生、艾伯维、诺华、UCB、礼来和百时美施贵宝。

本报告的见解将使负责人和企业经营团队能够就未来产品发布、高端市场策略、市场扩张和行销策略做出明智的决策。

全球银屑病干癣治疗市场报告涉及该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进入者和金融分析师。

相关人员可以透过用于分析全球银屑病干癣治疗市场的各种策略矩阵来促进他们的决策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 12.19 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	9.80%	2032 Value Projection:	USD 23.47 Bn

Psoriatic arthritis is a chronic inflammatory arthritis that occurs in conjunction with psoriasis. It is estimated that around 30% of people with psoriasis may develop psoriatic arthritis. The disease causes pain, stiffness and swelling in and around the joints. Over time, psoriatic arthritis can cause permanent damage to the joints. Conventional treatments including disease-modifying antirheumatic drugs (DMARDs) such as methotrexate and TNF inhibitors are used to manage the symptoms. Global psoriatic arthritis treatment market growth is driven by rising development and approval of novel targeted biologic therapies with better safety and efficacy profiles.

Market Dynamics:

Global psoriatic arthritis treatment market growth is driven by growing prevalence of psoriatic arthritis worldwide. According to estimates, the global prevalence of the disease ranges between 0.06% to 1%. Moreover, increasing awareness about the disease and availability of advanced treatments can also drive the market growth. However, high cost of biologic therapies can hamper the market growth, especially in price-sensitive developing regions. Continued efforts by market players to develop cost-effective generic versions of biologics can reduce costs over time. Furthermore, rising healthcare expenditures in emerging nations can offer new opportunities for the market players in the near future.

Key features of the study:

This report provides in-depth analysis of the global psoriatic arthritis treatment market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global psoriatic arthritis treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Pfizer, Johnson & Johnson, AbbVie, Novartis, UCB, Eli Lilly, Bristol-Myers Squibb

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global psoriatic arthritis treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global psoriatic arthritis treatment market

Detailed Segmentation-

Drug Class Insights (Revenue, USD Bn, 2020 - 2032)
- Biologics
- Non-biologics
- Combination Therapy
Product Type Insights (Revenue, USD Bn, 2020 - 2032)
- Prescription
- Over-The-Counter (OTC)
Route of Administration Insights (Revenue, USD Bn, 2020 - 2032)
- Parenteral
- Oral
Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Medtronic
- Johnson & Johnson (DePuy Synthes)
- Zimmer Biomet
- Stryker
- Xtant Medical
- RTI Surgical
- SeaSpine
- Arthrex
- HansBioMed
- Exactech
- Wright Medical Group
- Bioventus
- Integra LifeSciences
- AlloSource
- Medline Industries
- Osiris Therapeutics
- Acelity
- Orthofix
- MTF Biologics
- Cerapedics

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Psoriatic Arthritis Treatment Market, By Drug Class
- Global Psoriatic Arthritis Treatment Market, By Product Type
- Global Psoriatic Arthritis Treatment Market, By Route of Administration
- Global Psoriatic Arthritis Treatment Market, By Distribution Channel
- Global Psoriatic Arthritis Treatment Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Psoriatic Arthritis Treatment Market, By Drug Class, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Biologics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Non-biologics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Combination Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Psoriatic Arthritis Treatment Market, By Product Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Prescription
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Over-The-Counter (OTC)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Psoriatic Arthritis Treatment Market, By Route of Administration, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Psoriatic Arthritis Treatment Market, By Distribution Channel, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Psoriatic Arthritis Treatment Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025,2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021- 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

Medtronic
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Johnson & Johnson (DePuy Synthes)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Zimmer Biomet
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Stryker
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Xtant Medical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
RTI Surgical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
SeaSpine
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Arthrex
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
HansBioMed
Exactech
Wright Medical Group
Bioventus
Integra LifeSciences
AlloSource
Medline Industries
Osiris Therapeutics
Acelity
Orthofix
MTF Biologics
Cerapedics

10. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

11. References and Research Methodology

References
Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

银屑病干癣治疗市场按药物类别、产品类型、给药途径、分销管道和地区划分